BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 2017;12:287-99. [DOI: 10.1007/s11739-016-1599-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu L, Yan H, Wang Y, Xie Y, Jiang L, Zhao J, Gao C, Li X, Wang C. Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis. Front Immunol 2022;13:1012513. [PMID: 36524110 DOI: 10.3389/fimmu.2022.1012513] [Reference Citation Analysis]
2 Adam Z, Dastych M, Čermák A, Doubková M, Skorkovská Š, Pour L, Řehák Z, Koukalová R, Adamová Z, Štork M, Krejčí M, Boichuk I, Král Z. Therapy of immunoglonuline IgG4 related disease (IgG4-RD). Vnitr Lek 2022;68:E15-E22. [DOI: 10.36290/vnl.2022.086] [Reference Citation Analysis]
3 Mukai S, Sakamoto N, Kakinoki H, Shibuya T, Moriya R, Nishihara K, Noguchi M, Shin T, Fujimoto N, Igawa T, Ishii T, Haga N, Enokida H, Eto M, Kamba T, Sakai H, Saito S, Terada N, Kamoto T. Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis. J Clin Med 2022;11:3538. [PMID: 35743608 DOI: 10.3390/jcm11123538] [Reference Citation Analysis]
4 Covelli C, Carosi I, Graziano P, Ascani S. When idiopathic retroperitoneal fibrosis mimics Castleman disease: a challenging differential diagnosis. BMJ Case Rep 2022;15:e248051. [PMID: 35393274 DOI: 10.1136/bcr-2021-248051] [Reference Citation Analysis]
5 Nakada K, Kumagai S, Muraki O, Suzuki S. A case of IgG4-related retroperitoneal fibrosis diagnosed by tissue biopsy. FUKUSHIMA MEDICAL JOURNAL 2022;72:65-71. [DOI: 10.5387/fmedj.72.2_65] [Reference Citation Analysis]
6 Sanda M, Kamiya N, Sugizaki Y, Mori T, Sugiyama M, Kato S, Oka R, Utsumi T, Endo T, Yano M, Hiruta N, Suzuki H. SIGNIFICANCE OF IgG4 IN IDIOPATHIC RETROPERITONEAL FIBROSIS. Jpn j urol 2021;112:192-198. [DOI: 10.5980/jpnjurol.112.192] [Reference Citation Analysis]
7 Zongfei J, Lijuan Z, Ying S, Dongmei L, Sifan W, Xiufang K, Lingying M, Yun L, Lili M, Huiyong C, Lindi J. Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry. Ther Adv Chronic Dis 2021;12:20406223211028776. [PMID: 34262681 DOI: 10.1177/20406223211028776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Li R, Fei S, Lv Y, Kong X, Mao W. A case of idiopathic retroperitoneal fibrosis presenting as gallbladder carcinoma. BMC Surg 2021;21:162. [PMID: 33765983 DOI: 10.1186/s12893-021-01162-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Masaki C, Matsushita K, Inoue T, Shima H, Chikakiyo M, Yamada M, Shirono R, Tashiro M, Tada H, Takamatsu N, Wariishi S, Okada K, Minakuchi J. Splenic abscess diagnosed following relapsing sterile peritonitis in a peritoneal dialysis patient: A case report with literature review. Semin Dial 2021;34:245-51. [PMID: 33609413 DOI: 10.1111/sdi.12953] [Reference Citation Analysis]
10 Wang K, Wang Z, Zeng Q, Zhu L, Gao J, Wang Z, Zhang S, Yang F, Shen D, Wang Y, Liu Y. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One 2021;16:e0245601. [PMID: 33600452 DOI: 10.1371/journal.pone.0245601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Zhang Z, Guan W, Lin Q, Yu W. Thoracic paravertebral involvement in patients with IgG4-related disease: CT and MR imaging findings. Rheumatology (Oxford) 2020;59:3878-85. [PMID: 32556185 DOI: 10.1093/rheumatology/keaa254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kim Y, Choi HY. Immunoglobulin G4-Related Disease in the Thorax: Imaging Findings and Differential Diagnosis. J Korean Soc Radiol 2021;82:826. [DOI: 10.3348/jksr.2021.0078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Choi SJ, Oh JS, Hong S, Lee C, Yoo B, Hong B, Kim Y. Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio. J Rheum Dis 2021;28:38-44. [DOI: 10.4078/jrd.2021.28.1.38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sheth R, Malik D. Bilateral Hydronephrosis From Retroperitoneal Fibrosis. Cureus 2020;12:e12147. [PMID: 33489559 DOI: 10.7759/cureus.12147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Kawakami Y, Takada Y, Ishigami K, Hirano T, Wagatsuma K, Masaki Y, Murota A, Motoya M, Tsujiwaki M, Takahashi H, Nakase H. Idiopathic retroperitoneal fibrosis diagnosed by endoscopic ultrasonography-guided fine-needle biopsy. JGH Open 2021;5:151-2. [PMID: 33490626 DOI: 10.1002/jgh3.12431] [Reference Citation Analysis]
16 Raglianti V, Rossi GM, Vaglio A. Idiopathic retroperitoneal fibrosis: an update for nephrologists. Nephrol Dial Transplant 2020:gfaa083. [PMID: 33005943 DOI: 10.1093/ndt/gfaa083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
17 Oh JW, Rha SE, Choi MH, Oh SN, Youn SY, Choi JI. Immunoglobulin G4-related Disease of the Genitourinary System: Spectrum of Imaging Findings and Clinical-Pathologic Features. Radiographics 2020;40:1265-83. [PMID: 32870766 DOI: 10.1148/rg.2020200043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Akiyama M, Kaneko Y, Takeuchi T. Characteristics and prognosis of ANCA-positive retroperitoneal fibrosis: A systematic literature review. Autoimmun Rev 2020;19:102642. [PMID: 32801045 DOI: 10.1016/j.autrev.2020.102642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
19 Boyeva V, Alabsi H, Seidman MA, Paterson R, Kur J, Chen LYC, Chang SD, Carruthers M. Use of rituximab in idiopathic retroperitoneal fibrosis. BMC Rheumatol 2020;4:40. [PMID: 32775962 DOI: 10.1186/s41927-020-00140-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Roussel E, Callemeyn J, Van Moerkercke W. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature. Acta Clin Belg 2020;75:239-44. [PMID: 31035909 DOI: 10.1080/17843286.2019.1609152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Schleinitz N, Briantais A, Ebbo M. [IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria]. Rev Med Interne 2020;41:814-21. [PMID: 32732082 DOI: 10.1016/j.revmed.2020.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Lishchuk SV, Dubova EA, Pavlov KA, Borbat AM, Udalov YD. Clinical and morphological characteristics IgG4-associated retroperitoneal fibrosis. Alʹm klin med 2020;48:110-116. [DOI: 10.18786/2072-0505-2020-48-010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Brasselet D, Chouchana L, Vial T, Damin-pernik M, Lebrun-vignes B. Drug-induced retroperitoneal fibrosis: a case/non-case study in the French PharmacoVigilance Database. Expert Opinion on Drug Safety 2020;19:903-914. [DOI: 10.1080/14740338.2020.1766022] [Reference Citation Analysis]
24 Lanzillotta M, Campochiaro C, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L, Della-torre E. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes. Rheumatology 2020;59:2435-42. [DOI: 10.1093/rheumatology/keaa221] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
25 Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Erdheim–Chester disease: a rapidly evolving disease model. Leukemia 2020;34:2840-57. [DOI: 10.1038/s41375-020-0944-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
26 Peng L, Zhang P, Li J, Liu Z, Lu H, Zhu L, Wang X, Teng F, Li X, Guo H, Fei Y, Zhang W, Zhao Y, Zeng X, Zhang F. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther 2020;22:103. [PMID: 32366271 DOI: 10.1186/s13075-020-02197-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
27 Marvisi C, Accorsi Buttini E, Vaglio A. Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases. Presse Med 2020;49:104018. [PMID: 32234379 DOI: 10.1016/j.lpm.2020.104018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
28 Tanaka T, Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis. Int J Urol 2020;27:387-94. [PMID: 32166828 DOI: 10.1111/iju.14218] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
29 Urban ML, Maritati F, Palmisano A, Fenaroli P, Peyronel F, Trivioli G, Ferretti S, De Biase C, Grayson PC, Pegoraro F, Prisco D, Romagnani P, Emmi G, Vaglio A. Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients. Ann Rheum Dis 2020;79:433-4. [DOI: 10.1136/annrheumdis-2019-216258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
30 Nicastro M, Vescovini R, Maritati F, Palmisano A, Urban ML, Incerti M, Fenaroli P, Peyronel F, Benigno GD, Mangieri D, Volpi R, Becchi G, Romagnani P, Corradi D, Vaglio A. Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis. Arthritis Rheumatol 2019;71:1913-22. [DOI: 10.1002/art.41024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
31 Zhang W, Stone JH. Management of IgG4-related disease. The Lancet Rheumatology 2019;1:e55-65. [DOI: 10.1016/s2665-9913(19)30017-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
32 Lindholm KE, de Groot P, Moran CA. Fibrosing/Sclerosing Lesions of the Mediastinum: A Review. Adv Anat Pathol 2019;26:235-40. [PMID: 30608259 DOI: 10.1097/PAP.0000000000000223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Imazio M, Brucato A, Lazaros G. Aetiology search should be guided by clinical evaluation. Heart 2019;105:1129.2-1130. [DOI: 10.1136/heartjnl-2019-315263] [Reference Citation Analysis]
34 Raffiotta F, da Silva Escoli R, Quaglini S, Rognoni C, Sacchi L, Binda V, Messa P, Moroni G. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse. Am J Kidney Dis 2019;74:742-50. [PMID: 31204195 DOI: 10.1053/j.ajkd.2019.04.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
35 Maritati F, Rocco R, Accorsi Buttini E, Marvisi C, Nicastro M, Urban ML, Fenaroli P, Peyronel F, Benigno GD, Palumbo AA, Corradi D, Emmi G, Pipitone N, Palmisano A, Vaglio A. Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients. Front Immunol 2019;10:693. [PMID: 31019511 DOI: 10.3389/fimmu.2019.00693] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
36 Pérez-Sanz MT, Cervilla-Muñoz E, Alonso-Muñoz J, Marcelo-Ayala A, Pulfer MD, Galeano-Valle F. Retroperitoneal fibrosis associated with orbital pseudotumor without evidence of IgG4: A case report with review of literature. Intractable Rare Dis Res 2019;8:29-35. [PMID: 30881855 DOI: 10.5582/irdr.2018.01075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Mizushima I, Kasashima S, Fujinaga Y, Kawano M, Ishizaka N. IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening. Modern Rheumatology 2019;29:240-50. [DOI: 10.1080/14397595.2018.1546367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
38 Liao S, Zhang X, Zhu F, Wang Y, Zhu J, Zhang J, Huang F. Comparison of two subsets of Chinese patients with retroperitoneal fibrosis in terms of IgG4 immunohistochemical staining. Rheumatology (Oxford) 2019;58:455-62. [PMID: 30476270 DOI: 10.1093/rheumatology/key324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kalhor N, Moran C. Benign Tumors and Tumor-Like Conditions. Mediastinal Pathology 2019. [DOI: 10.1007/978-3-319-98980-8_4] [Reference Citation Analysis]
40 Dei Tos AP. Intermediate Malignant and Malignant Tumors of Soft Tissue Featuring an Inflammatory Background. Soft Tissue Sarcomas 2018. [DOI: 10.1017/9781316535097.011] [Reference Citation Analysis]
41 Martorana D, Márquez A, Carmona FD, Bonatti F, Adorni A, Urban ML, Maritati F, Accorsi Buttini E, Marvisi C, Palmisano A, Rossi GM, Trivioli G, Fenaroli P, Manenti L, Nicastro M, Incerti M, Gianfreda D, Bani S, Ferretti S, Corradi D, Alberici F, Emmi G, Di Scala G, Moroni G, Percesepe A, Scheel PJ, Vermeer E, van Bommel EF, Martín J, Vaglio A. A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis. Journal of Allergy and Clinical Immunology 2018;142:1662-5. [DOI: 10.1016/j.jaci.2018.06.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gumeler E, Onur MR, Karaosmanoglu AD, Ozmen M, Akata D, Karcaaltincaba M. Computed tomography and magnetic resonance imaging of peripelvic and periureteric pathologies. Abdom Radiol (NY) 2018;43:2400-11. [PMID: 29285599 DOI: 10.1007/s00261-017-1444-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
43 Liao S, Wang Y, Li K, Zhu J, Zhang J, Huang F. Idiopathic retroperitoneal fibrosis: a cross-sectional study of 142 Chinese patients. Scandinavian Journal of Rheumatology 2018;47:198-205. [DOI: 10.1080/03009742.2017.1363280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Wang Y, Guan Z, Gao D, Luo G, Li K, Zhao Y, Wang X, Zhang J, Jin J, Zhao Z, Yang C, Zhang J, Zhu J, Huang F. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum 2018;47:593-600. [PMID: 28958769 DOI: 10.1016/j.semarthrit.2017.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
45 Yadlapati S, Verheyen E, Efthimiou P. IgG4-related disease: a complex under-diagnosed clinical entity. Rheumatol Int 2018;38:169-77. [PMID: 28681251 DOI: 10.1007/s00296-017-3765-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
46 Brandt AS, Dreger NM, Müller E, Kukuk S, Roth S. Neue (und alte) Aspekte der retroperitonealen Fibrose. Urologe 2017;56:887-94. [DOI: 10.1007/s00120-017-0428-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]